United Parcel (UPS) Offering Possible 28.21% Return Over the Next 17 Calendar Days

United Parcel's most recent trend suggests a bullish bias. One trading opportunity on United Parcel is a Bull Put Spread using a strike $99.00 short put and a strike $94.00 long put offers a potential 28.21% return on risk over the next 17 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $99.00 by expiration. The full premium credit of $1.10 would be kept by the premium seller. The risk of $3.90 would be incurred if the stock dropped below the $94.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for United Parcel is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for United Parcel is bullish.

The RSI indicator is at 65.66 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for United Parcel

Hedge Funds Have Never Been This Bullish On United Parcel Service, Inc. (UPS)
Fri, 29 May 2020 16:23:47 +0000
In this article you are going to find out whether hedge funds think United Parcel Service, Inc. (NYSE:UPS) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus […]

UPS Slaps ‘Peak' Surcharge On Amazon, Walmart, Others, As Delivery Requests Balloon Post Lockdown Ease
Fri, 29 May 2020 08:38:58 +0000
United Parcel Services Inc. (NYSE: UPS) is imposing an additional fee for delivery requests from e-commerce companies that is common during peak seasons, Reuters reported Thursday.The move will come into effect on May 31 and apply to “large, high-volume shippers and companies that send oversized items,” according to Reuters.Major UPS clients include Amazon.com Inc. (NASDAQ: AMZN), Walmart Inc. (NYSE: WMT), and Target Corporation (NYSE: TGT), and all these companies are likely to be affected by the latest policy.The e-commerce companies have seen a sudden rise in business as authorities across the United States lifted the lockdowns and the companies are planning to restart deliveries of non-essential items.Delivery services like UPS, or rival FedEx Corporation (NYSE: FDX), typically impose these surcharges during the holiday season shopping surge.UPS and FedEx are also set to benefit from Amazon reportedly suspending its delivery service for third-party sellers on its platform starting June 1.UPS Price Action UPS shares closed 0.1% higher at $99.72 on Thursday and were mostly unchanged in the after-hours session.See more from Benzinga * FedEX, UPS Shares Surge As Amazon To Suspend Delivery Service For Third-Party Sellers Due To Increased Demand(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

UPS adds ‘peak' surcharge amid coronavirus fueled delivery spike
Fri, 29 May 2020 02:24:12 +0000
United Parcel Service Inc on May 31 will slap surcharges on U.S. e-commerce companies that have flooded its delivery network with shipments of everything from packaged food to patio furniture since the coronavirus took hold in March. Such fees are common during the winter holiday season, when package volumes more than double. This round follows stay-at-home orders to fight the spread of the novel coronavirus.

United Parcel Service (UPS) Gains As Market Dips: What You Should Know
Thu, 28 May 2020 21:50:09 +0000
United Parcel Service (UPS) closed the most recent trading day at $99.72, moving +0.1% from the previous trading session.

CVS, Nuro to test driverless prescription delivery in Houston area
Thu, 28 May 2020 18:53:34 +0000
CVS Health Corp and unmanned vehicle delivery Nuro in June will start testing a service that drops prescriptions and other essentials free of charge to some customers in the Houston area, the companies said on Thursday. CVS and other companies are experimenting with myriad ways to serve customers who may be reluctant or unable to visit stores due to the coronavirus pandemic, which has fueled demand for home delivery of everything from groceries and medicine to patio furniture and gardening supplies. Mountain View, California-based Nuro said in a blog post that the service in Houston will launch with its autonomous Prius fleet and then switch in subsequent months to R2, its low-speed, custom-built delivery bot.

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.